Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells
- 1 December 2004
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 21 (5) , 461-467
- https://doi.org/10.1007/s10585-004-2724-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects of α-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude miceClinical & Experimental Metastasis, 2003
- Adjuvant systemic therapy for early breast cancer: progress and controversies.2001
- The Role of Osteopontin in Breast Cancer: Clinical and Experimental StudiesJournal of Mammary Gland Biology and Neoplasia, 2001
- Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1Nature Medicine, 2000
- Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.1999
- Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cellsOncogene, 1999
- Cooperativity between the polyamine pathway and HER-2neu in transformation of human mammary epithelial cells in culture: Role of the MAPK pathwayInternational Journal of Cancer, 1998
- Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cellsCell, 1994
- Recombinant GST‐human osteopontin fusion protein is functional in RGD‐dependent cell adhesionJournal of Cellular Biochemistry, 1994
- POLYAMINE INVOLVEMENT IN THE GROWTH OF HORMONE-RESPONSIVE AND HORMONE-RESISTANT HUMAN-BREAST CANCER-CELLS IN CULTURE1989